Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Petersen, Troels R ^a   Sika Paotonu, Dianne ^a   Knight, Deborah A ^a   Simkins, Helen M A ^a   Hermans, Ian F ^a,b  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD8ALPHA ANTIGEN; DENDRITIC CELL VACCINE; INTERLEUKIN 12; LANGERIN; CD207 PROTEIN, MOUSE; GAMMA INTERFERON; INTERLEUKIN 4; LECTIN; MANNOSE BINDING LECTIN; MEMBRANE ANTIGEN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IN VIVO STUDY; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSACTIVATION; ANIMAL; ANTIGEN PRESENTING CELL; BLOOD; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL CULTURE; CYTOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; MOUSE MUTANT; NATURAL KILLER CELL;

MUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, SURFACE; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-4; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOID TISSUE; MANNOSE-BINDING LECTINS; MICE; MICE, MUTANT STRAINS; VACCINES;

EID: 79953313061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017657     Document Type: Article

References (57)

1. Henri S, Vremec D, Kamath A, Waithman J, Williams S, et al. (2001) The dendritic cell populations of mouse lymph nodes. J Immunol 167: 741-748.
2. Shortman K, Naik SH, (2007) Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7: 19-30.
3. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K, (2000) CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 164: 2978-2986.
4. McLellan AD, Kapp M, Eggert A, Linden C, Bommhardt U, et al. (2002) Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood 99: 2084-2093.
5. den Haan JM, Lehar SM, Bevan MJ, (2000) CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192: 1685-1696.
6. Iyoda T, Shimoyama S, Liu K, Omatsu Y, Akiyama Y, et al. (2002) The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 195: 1289-1302.
7. Pooley JL, Heath WR, Shortman K, (2001) Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol 166: 5327-5330.
8. Schnorrer P, Behrens GM, Wilson NS, Pooley JL, Smith CM, et al. (2006) The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci U S A 103: 10729-10734.
9. Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, et al. (2001) Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol 166: 5448-5455.
10. Edwards AD, Manickasingham SP, Sporri R, Diebold SS, Schulz O, et al. (2002) Microbial recognition via Toll-like receptor-dependent and-independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J Immunol 169: 3652-3660.
11. Allan R, Waithman J, Bedoui S, Jones C, Villadangos J, et al. (2006) Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL Priming. Immunity 25: 153-162.
12. Belz GT, Smith CM, Kleinert L, Reading P, Brooks A, et al. (2004) Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc Natl Acad Sci U S A 101: 8670-8675.
13. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, et al. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6: 1219-1227.
14. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, et al. (1998) Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 188: 2163-2173.
15. Kleindienst P, Brocker T, (2003) Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J Immunol 170: 2817-2823.
16. Millrain M, Scott D, Addey C, Dewchand H, Ellis P, et al. (2005) Identification of the immunodominant HY H2-D(k) epitope and evaluation of the role of direct and indirect antigen presentation in HY responses. J Immunol 175: 7209-7217.
17. Yewdall AW, Drutman SB, Jinwala F, Bahjat KS, Bhardwaj N CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cell. PLoS One 5: e11144.
18. Farrand KJ, Dickgreber N, Stoitzner P, Ronchese F, Petersen TR, et al. (2009) Langerin+CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. J Immunol 183: 7732-7742.
19. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM, (2003) Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198: 267-279.
20. Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, et al. (2003) NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171: 5140-5147.
21. Stober D, Jomantaite I, Schirmbeck R, Reimann J, (2003) NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo. J Immunol 170: 2540-2548.
22. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM, (2004) The Linkage of Innate to Adaptive Immunity via Maturing Dendritic Cells In Vivo Requires CD40 Ligation in Addition to Antigen Presentation and CD80/86 Costimulation. J Exp Med 199: 1607-1618.
23. Hermans IF, Silk JD, Gileadi U, Masri SH, Shepherd D, et al. (2007) Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. J Immunol 178: 2721-2729.
24. Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, et al. (2004) Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest 114: 1800-1811.
25. Kelly JM, Sterry SJ, Cose S, Turner SJ, Fecondo J, et al. (1993) Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant. Eur J Immunol 23: 3318-3326.
26. Barnden MJ, Allison J, Heath WR, Carbone FR, (1998) Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76: 34-40.
27. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, et al. (2005) Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
28. Chen YH, Chiu NM, Mandal M, Wang N, Wang CR, (1997) Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity 6: 459-467.
29. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752.
30. Lee A, Farrand KJ, Dickgreber N, Hayman CM, Jurs S, et al. (2006) Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity. Carbohydr Res 341: 2785-2798.
31. Semmling V, Lukacs-Kornek V, Thaiss CA, Quast T, Hochheiser K, et al. (2010) Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol 11: 313-320.
32. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, et al. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629.
33. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, et al. (1998) CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 188: 1521-1528.
34. Spada FM, Koezuka Y, Porcelli SA, (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 188: 1529-1534.
35. Tomura M, Yu WG, Ahn HJ, Yamashita M, Yang YF, et al. (1999) A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol 163: 93-101.
36. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, et al. (1999) The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 189: 1121-1128.
37. Carnaud C, Lee D, Donnars O, Park S-H, Beavis A, et al. (1999) Cross-Talk Between Cells of the Innate Immune System: NKT Cells Rapidly Activate NK Cells. J Immunol 163: 4647-4650.
38. Taraban VY, Martin S, Attfield KE, Glennie MJ, Elliott T, et al. (2008) Invariant NKT cells promote CD8+ cytotoxic T cell responses by inducing CD70 expression on dendritic cells. J Immunol 180: 4615-4620.
39. Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, et al. (2006) Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 211: 81-92.
40. Bursch L, Wang L, Igyarto B, Kissenpfennig A, Malissen B, et al. (2007) Identification of a novel population of Langerin+ dendritic cells. J Exp Med 204: 3147-3156.
41. Takahara K, Omatsu Y, Yashima Y, Maeda Y, Tanaka S, et al. (2002) Identification and expression of mouse Langerin (CD207) in dendritic cells. Int Immunol 14: 433-444.
42. Sung SS, Fu SM, Rose CE Jr, Gaskin F, Ju ST, et al. (2006) A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 176: 2161-2172.
43. GeurtsvanKessel CH, Willart MA, van Rijt LS, Muskens F, Kool M, et al. (2008) Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J Exp Med 205: 1621-1634.
44. Creusot RJ, Yaghoubi SS, Chang P, Chia J, Contag CH, et al. (2009) Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood 113: 6638-6647.
45. Harshyne LA, Watkins SC, Gambotto A, Barratt-Boyes SM, (2001) Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 166: 3717-3723.
46. Thery C, Duban L, Segura E, Veron P, Lantz O, et al. (2002) Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 3: 1156-1162.
47. Fleeton MN, (2004) Peyer's Patch Dendritic Cells Process Viral Antigen from Apoptotic Epithelial Cells in the Intestine of Reovirus-infected Mice. J Exp Med 200: 235-245.
48. Lin ML, Zhan Y, Proietto AI, Prato S, Wu L, et al. (2008) Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc Natl Acad Sci U S A 105: 3029-3034.
49. Idoyaga J, Suda N, Suda K, Park CG, Steinman R, (2009) Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proc Natl Acad Sci U S A 106: 1524-1529.
50. Qiu C, Miyake Y, Kaise H, Kitamura H, Ohara O, et al. (2009) Novel Subset of CD8 + Dendritic Cells Localized in the Marginal Zone Is Responsible for Tolerance to Cell-Associated Antigens. J Immunol 182: 4127-4136.
51. Li M, Davey GM, Sutherland RM, Kurts C, Lew AM, et al. (2001) Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 166: 6099-6103.
52. Shimizu K, Kurosawa Y, Taniguchi M, Steinman R, Fujii S, (2007) Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell-mediated immunity via dendritic cells. J Exp Med 204: 2641-2653.
53. Schulz O, Reis e Sousa C, (2002) Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107: 183-189.
54. Barral P, Polzella P, Bruckbauer A, Rooijen Nv, Besra GS, et al. (2010) CD169+ macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol pp. 1-12.
55. Finkelman FD, Lees A, Birnbaum R, Gause WC, Morris SC, (1996) Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 157: 1406-1414.
56. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, et al. (2002) Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196: 1627-1638.
57. Bonifaz L, (2004) In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination. J Exp Med 199: 815-824.